Home › Stocks › BLRX

BLRX — BIOLINE RX LIMITED

Reported value held$388.06M
Funds holding (latest)63
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)17
Institutional value$1.33M · 567.77K sh
New / Add / Cut / Exit5 / 4 / 2 / 3 · Updated 2026-11-17
Top-5 / Top-10 concentration99.1% / 99.9%
Institutional holdings change Accumulating +12.5% (+8.25K sh)
Institutional value change Down -14.9%

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingStrong Buy
Analysts covering2
12-month price target$22.00 (+1813.0%)
Last price at fetch$1.15
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)+0.00
Revision score (year)+0.00
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Sep 2026 -0.38 — 0.00 -0.77 2 —
Dec 2026 -0.40 — 0.00 -0.80 2 —
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -1.57 — 0.00 -3.14 2 —
Dec 2027 -1.26 — 0.00 -2.52 2 —
Dec 2028 0.00 — 0.00 0.00 1 —

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 17 SEC-registered investment managers reported holding BLRX (BIOLINE RX LIMITED) in their latest 13F filings, with a combined reported value of $1.33M across 567.77K shares. That is +12.5% by share count (+8.25K shares) versus the previous quarter, while reported value moved -14.9%. Ownership is concentrated: the five largest holders account for 99.1% of reported value and the top ten for 99.9%.

Compared with the prior quarter, 5 opened new positions, 4 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of BIOLINE RX LIMITED (BLRX) include SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 63 institutional holders on this page.

BLRX is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 17 567.77K $1.33M +12.5%
Q2 2026 15 66.60K $1.21M +93.9%
Q1 2026 13 29.80K $68.79K -21.9%
Q4 2025 14 22.80K $64.52K -30.6%
Q3 2025 15 47.99K $181.42K +31.4%
Q2 2025 18 52.55K $240.34K +14.7%
Q1 2025 12 9.46K $28.00K -95.8%
Q4 2024 30 1.92M $408.12K -11.6%

Over the 8 quarters shown, institutional share counts decreased 70% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (-95.8%).

Top Institutional Holders (Q3 2026) — 17 funds

FundSharesValuePortfolio WeightChange
ARMISTICE CAPITAL, LLC 473.00K $1.11M 0.01% New
Citadel Advisors 30.09K $70.70K 0.00% Add
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.55K $48.30K 0.00% Reduce
STIFEL FINANCIAL CORP 20.04K $47.10K 0.00% New
Renaissance Technologies 18.90K $44.41K 0.00% Add
RHUMBLINE ADVISERS 2.48K $5.82K 0.00% Hold
Wells Fargo & Co 1.75K $4.11K 0.00% Reduce
Nemes Rush Group LLC 250 $588 0.00% Hold
SIMPLEX TRADING, LLC 200 $470 0.00% New
Tower Research Capital LLC (TRC) 181 $425 0.00% New
UBS Group AG 157 $369 0.00% Add
NewEdge Advisors, LLC 82 $193 0.00% Hold
OSAIC HOLDINGS, INC. 51 $119 0.00% Add
BFC Planning, Inc. 28 $66 0.00% Hold
SBI Securities Co., Ltd. 10 $24 0.00% Hold
Caitong International Asset Management Co., Ltd 2 $5 0.00% New
DANSKE BANK A/S 2 $5 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 15 funds

FundSharesValuePortfolio WeightChange
Banque Cantonale Vaudoise 1 $1.00M 0.00% New
SUSQUEHANNA INTERNATIONAL GROUP, LLP 30.91K $95.82K 0.00% Add
Renaissance Technologies 15.41K $48.09K 0.00% New
Citadel Advisors 14.80K $45.87K 0.00% New
RHUMBLINE ADVISERS 2.48K $7.68K 0.00% Add
Wells Fargo & Co 2.00K $6.24K 0.00% Add
BNP PARIBAS FINANCIAL MARKETS 500 $1.55K 0.00% Reduce
Nemes Rush Group LLC 250 $780 0.00% Hold
UBS Group AG 101 $315 0.00% Reduce
NewEdge Advisors, LLC 82 $256 0.00% Reduce
BFC Planning, Inc. 28 $87 0.00% New
OSAIC HOLDINGS, INC. 26 $81 0.00% Hold
SBI Securities Co., Ltd. 10 $31 0.00% New
DANSKE BANK A/S 2 $6 0.00% Hold
Citigroup Inc 1 $3 0.00% Reduce

Q1 2026 — 13 funds

FundSharesValuePortfolio WeightChange
XTX Topco Ltd 10.94K $25.27K 0.00% New
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10.20K $23.56K 0.00% New
RHUMBLINE ADVISERS 2.35K $5.43K 0.00% Reduce
BNP PARIBAS FINANCIAL MARKETS 1.80K $4.14K 0.00% Add
Wells Fargo & Co 1.75K $4.03K 0.00% Hold
Citigroup Inc 1.73K $3.99K 0.00% Reduce
UBS Group AG 529 $1.22K 0.00% Reduce
Nemes Rush Group LLC 250 $575 0.00% Hold
NewEdge Advisors, LLC 107 $247 0.00% Hold
Morgan Stanley 100 $230 0.00% Hold
OSAIC HOLDINGS, INC. 26 $59 0.00% Hold
Rockefeller Capital Management L.P. 12 $28 0.00% Hold
DANSKE BANK A/S 2 $5 0.00% Hold

Q4 2025 — 14 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 11.60K $33.06K 0.00% Add
RHUMBLINE ADVISERS 3.35K $9.55K 0.00% Add
Citigroup Inc 2.04K $5.81K 0.00% New
UBS Group AG 1.95K $5.40K 0.00% Reduce
Wells Fargo & Co 1.75K $4.85K 0.00% Hold
BNP PARIBAS FINANCIAL MARKETS 1.50K $4.16K 0.00% New
Nemes Rush Group LLC 250 $693 0.00% Hold
NewEdge Advisors, LLC 107 $296 0.00% Hold
GROUP ONE TRADING LLC 100 $285 0.00% Reduce
Morgan Stanley 100 $277 0.00% Reduce
OSAIC HOLDINGS, INC. 26 $71 0.00% Add
Rockefeller Capital Management L.P. 12 $33 0.00% Hold
Bank of America Corp 10 $28 0.00% Add
DANSKE BANK A/S 2 $6 0.00% Hold

Q3 2025 — 15 funds

FundSharesValuePortfolio WeightChange
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.20K $76.36K 0.00% Add
Citadel Advisors 10.02K $37.88K 0.00% Reduce
UBS Group AG 6.39K $24.14K 0.00% New
Morgan Stanley 5.95K $22.50K 0.00% Add
RHUMBLINE ADVISERS 3.07K $11.60K 0.00% Reduce
Wells Fargo & Co 1.75K $6.62K 0.00% Hold
Nemes Rush Group LLC 250 $945 0.00% Hold
GROUP ONE TRADING LLC 200 $756 0.00% Reduce
NewEdge Advisors, LLC 107 $405 0.00% Hold
Tower Research Capital LLC (TRC) 39 $147 0.00% New
Rockefeller Capital Management L.P. 12 $45 0.00% New
Bank of America Corp 2 $8 0.00% Hold
DANSKE BANK A/S 2 $8 0.00% Hold
SBI Securities Co., Ltd. 2 $8 0.00% Hold
OSAIC HOLDINGS, INC. 1 $3 0.00% Hold

Q2 2025 — 18 funds

FundSharesValuePortfolio WeightChange
TWO SIGMA SECURITIES, LLC 13.82K $63.14K 0.01% New
Citadel Advisors 12.20K $55.75K 0.00% New
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11.10K $50.72K 0.00% New
RHUMBLINE ADVISERS 4.28K $19.53K 0.00% Add
Citigroup Inc 4.00K $18.30K 0.00% New
SIMPLEX TRADING, LLC 3.00K $13.00K 0.00% New
Wells Fargo & Co 1.75K $8.00K 0.00% Reduce
Morgan Stanley 1.54K $7.05K 0.00% Reduce
GROUP ONE TRADING LLC 400 $1.83K 0.00% Add
Nemes Rush Group LLC 250 $1.14K 0.00% Reduce
NATIONAL BANK OF CANADA /FI/ 2 $914 0.00% New
NewEdge Advisors, LLC 107 $489 0.00% Hold
RAYMOND JAMES FINANCIAL INC 72 $329 0.00% New
FIFTH THIRD BANCORP 25 $114 0.00% New
Bank of America Corp 2 $9 0.00% Hold
DANSKE BANK A/S 2 $9 0.00% Hold
SBI Securities Co., Ltd. 2 $9 0.00% Hold
OSAIC HOLDINGS, INC. 1 $4 0.00% New

View all 63 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
ARMISTICE CAPITAL, LLC 473.00K — — — — — — — — — — — — — — — — — — —
Citadel Advisors 30.09K 14.80K — 11.60K 10.02K 12.20K — 5.10K 6.30K 11.20K 12.20K 4.40K 4.20K 257.67K — — — 33.07K 11.00K 44.80K
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.55K 30.91K 10.20K — 20.20K 11.10K — 87.22K 18.03K 110.50K 172.10K 80.00K 103.00K — — — — — — —
STIFEL FINANCIAL CORP 20.04K — — — — — — — — — — — — — — — — — — —
Renaissance Technologies 18.90K 15.41K — — — — — — — — — — — 98.71K 106.09K 257.90K 68.22K 45.74K 67.35K 14.10K
RHUMBLINE ADVISERS 2.48K 2.48K 2.35K 3.35K 3.07K 4.28K 1.53K 42.96K 32.61K 25.74K 18.33K 18.80K 15.34K — — — — — — —
Wells Fargo & Co 1.75K 2.00K 1.75K 1.75K 1.75K 1.75K 3.00K 5.54K 35.03K 56.03K 32.03K 8.54K 8.54K 35 35 35 — — — 703
Nemes Rush Group LLC 250 250 250 250 250 250 300 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K — — — — — — —
SIMPLEX TRADING, LLC 200 — — — — 3.00K — — 3.10K 2.80K 1.98K 6.40K 1.20K — — — — — — —
Tower Research Capital LLC (TRC) 181 — — — 39 — — — — — — — — — — — — — — —
UBS Group AG 157 101 529 1.95K 6.39K — 71 9.20K 984 1.48K 12.57K 300 9.28K 10.54K — 3.83K 12.79K — — —
NewEdge Advisors, LLC 82 82 107 107 107 107 107 4.30K 4.30K 4.30K 4.30K 4.30K 4.30K — — — — — — —
OSAIC HOLDINGS, INC. 51 26 26 26 1 1 — 1.21K 1.21K 1.41K 1.21K 14.32K 24.20K — — — — — — —
BFC Planning, Inc. 28 28 — — — — — — — — — — — — — — — — — —
SBI Securities Co., Ltd. 10 10 — — 2 2 2 3.10K — — — — — — — — — — — —
DANSKE BANK A/S 2 2 2 2 2 2 2 — — — — — — — — — — — — —
Caitong International Asset Management Co., Ltd 2 — — — — — — — — — — — — — — — — — — —
SABBY MANAGEMENT, LLC — — — — — — — — — — — — 210.00K — — — — — — —
Alyeska Investment Group, L.P. — — — — — — — — 866.50K 1.95M — — — — — — — — — —
Banque Cantonale Vaudoise — 1 — — — — — — — — — — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold BLRX?

As of 2026-Q3, 17 institutional funds reported holding BLRX (BIOLINE RX LIMITED) in SEC 13F filings, with a combined reported value of $1.33M.

How many shares of BLRX do institutions own?

13F filers reported 567.77K shares of BLRX, worth $1.33M in aggregate at the end of 2026-Q3.

Is institutional ownership of BLRX rising or falling?

Share counts moved +12.5% versus the prior quarter — accumulation.

Who are the top institutional holders of BLRX?

The largest 13F holders are SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, Banque Cantonale Vaudoise, Alyeska Investment Group, L.P.; the top 25 are ranked at the top of this page.

Who are the major shareholders of BIOLINE RX LIMITED?

The major shareholders of BIOLINE RX LIMITED (BLRX) by reported 13F value are SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, Banque Cantonale Vaudoise, Alyeska Investment Group, L.P., among 63 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own BLRX" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/BLRX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →